StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > STAGE ZERO LIFE SCIENCE

<< Previous

Bullboard Posts

Next >>

Comment by RelevantStockon Feb 15, 2021 8:31pm

129 Views

Post# 32570245

RE:RE:RE:STAGE ZERO LIFE SCIENCE

haha bs my average is a little bit lower 6.5 cent pre rs. I trade mostly on rhe nasdaq and i've been very lucky this year, stagezero is the little straggler in my current portfolio, but everything is mostly swing trades. But I like the stock potential and most of the real longs on this board so...

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?